다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기
Nephrology, v.5 no.4, 2000년, pp.209 - 213
Cattran, Daniel
AI-Helper
SUMMARY: The Management of membranous nephropathy requires a recognition of its natural history and an ability to predict those pationts with the worst prognosis. Treatment of those at risk of progression with immunosuppressive drugs should be accompanied by additional conservative risk reduction st...
Haas, M., Meehan, S.M., Karrison, T.G., Spargo, B.H.. Changing etiologies of unexplained adult nephrotic syndrome: A comparison of renal biopsy findings from 1976-1979 and 1995-1997. American journal of kidney diseases : the official journal of the National Kidney Foundation, vol.30, no.5, 621-631.
Nephrol. Dial. Transplant Honkanen E 35 7 1992 Natural history, clinical course and morphological evolution of membranous nephropathy.
Hall, C L, Jawad, S, Harrison, P R, MacKenzie, J C, Bacon, P A, Klouda, P T, MacIver, A G. Natural course of penicillamine nephropathy: a long term study of 33 patients. British medical journal, vol.296, no.6629, 1083-1086.
Burstein, David M., Korbet, Stephen M., Schwartz, Melvin M.. Membranous Glomerulonephritis and Malignancy. American journal of kidney diseases : the official journal of the National Kidney Foundation, vol.22, no.1, 5-10.
Nephrol. Dial. Transplant Cattran DC 48 7 1992 Predicting progression in membranous glomerulonephritis.
Hogan, S.L., Muller, K.E., Jennette, J., Falk, R.J.. A review of therapeutic studies of idiopathic membranous glomerulopathy. American journal of kidney diseases : the official journal of the National Kidney Foundation, vol.25, no.6, 862-875.
Schieppati, Arrigo, Mosconi, Lidia, Perna, Annalisa, Mecca, Giuliano, Bertani, Tullio, Garattini, Silvio, Remuzzi, Giuseppe. Prognosis of Untreated Patients with Idiopathic Membranous Nephropathy. The New England journal of medicine, vol.329, no.2, 85-89.
Cattran, Daniel C., Pei, York, Greenwood, Celia M.T., Ponticelli, Claudio, Passerini, Patrizia, Honkanen, Eero. Validation of a predictive model of idiopathic membranous nephropathy: Its clinical and research implications. Kidney international, vol.51, no.3, 901-907.
Cattran, Daniel C., Delmore, Terry, Roscoe, Janet, Cole, Edward, Cardella, Carl, Charron, Richard, Ritchie, Susan. A Randomized Controlled Trial of Prednisone in Patients with Idiopathic Membranous Nephropathy. The New England journal of medicine, vol.320, no.4, 210-215.
CAMERON, J. STEWART, HEALY, M. J. R., ADU, D.. The Medical Research Council Trial of Short-term High-dose Alternate Day Prednisolone in Idiopathic Membranous Nephropathy with Nephrotic Syndrome in Adults. The Quarterly journal of medicine, vol.74, no.2, 133-156.
Ponticelli, Claudio, Zucchelli, Pietro, Passerini, Patrizia, Cesana, Bruno, Locatelli, Francesco, Pasquali, Sonia, Sasdelli, Mauro, Redaelli, Bruno, Grassi, Claudio, Pozzi, Claudio, Bizzarri, Daniela, Banfi, Giovanni. A 10-year follow-up of a randomized study with methylprednisolone and chlorambucil in membranous nephropathy. Kidney international, vol.48, no.5, 1600-1604.
J. Am. Soc. Nephrol. Ponticelli C 444 9 1998 10.1681/ASN.V93444 A randomized study comparing methylprednisolone plus chlorambucil versus methylprednisolone plus cyclophosphamide in idiopathic membranous nephropathy.
Q.J. Med Warwick GI 223 87 1994 Prednisolone and chlorambucil therapy for idiopathic membranous nephropathy with progressive renal failure.
Falk, Ronald J., Hogan, Susan L., Muller, Keith E., Jennette, J. Charles. Treatment of Progressive Membranous Glomerulopathy : A Randomized Trial Comparing Cyclophosphamide and Corticosteroids with Corticosteroids Alone. Annals of internal medicine, vol.116, no.6, 438-445.
Cattran, Daniel C., Greenwood, Celia, Ritchie, Susan, Bernstein, Keevin, Churchill, David N., Clark, William F., Morrin, Peter A., Lavoie, Susan. A controlled trial of cyclosporine in patients with progressive membranous nephropathy. Kidney international, vol.47, no.4, 1130-1135.
Fritsche, L, Budde, K, Färber, L, Charissé, G, Kunz, R, Gaedeke, J, Neumayer, H H. Treatment of membranous glomerulopathy with cyclosporin A: how much patience is required?. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, vol.14, no.4, 1036-1038.
Klahr, Saulo, Levey, Andrew S., Beck, Gerald J., Caggiula, Arlene W., Hunsicker, Lawrence, Kusek, John W., Striker, Gary. The Effects of Dietary Protein Restriction and Blood-Pressure Control on the Progression of Chronic Renal Disease. The New England journal of medicine, vol.330, no.13, 877-884.
Nephrol. Dial. Transplant. Gansevoort RT 1963 10 1995 Antiproteinuric effect of blood‐pressure‐lowering agents. a meta‐analysis of comparative trials.
Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy. The Lancet, vol.349, no.9069, 1857-1863.
Nephrology, Dialysis, Transplantation Rostoker G 25 10 1995 Low‐dose angiotensin‐converting‐enzyme inhibitor captopril to reduce proteinuria in adult idiopathic membranous nephropathy: a prospective study of long‐term treatment.
Wheeler, David C., Bernard, David B.. Lipid Abnormalities in the Nephrotic Syndrome: Causes, Consequences, and Treatment. American journal of kidney diseases : the official journal of the National Kidney Foundation, vol.23, no.3, 331-346.
Wagoner, Richard D., Stanson, Anthony W., Holley, Keith E., Winter, Christine S.. Renal vein thrombosis in idiopathic membranous glomerulopathy and nephrotic syndrome: Incidence and significance. Kidney international, vol.23, no.2, 368-374.
Bellomo, Rinaldo, Atkins, Robert C.. Membranous Nephropathy and Thromboembolism: Is Prophylactic Anticoagulation Warranted?. Nephron, vol.63, no.3, 249-254.
해당 논문의 주제분야에서 활용도가 높은 상위 5개 콘텐츠를 보여줍니다.
더보기 버튼을 클릭하시면 더 많은 관련자료를 살펴볼 수 있습니다.
Copyright KISTI. All Rights Reserved.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.